Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide

OBJECTIVES: To evaluate the potential prognostic utility of pretreatment systemic immune-inflammation index (SII) in newly diagnosed glioblastoma multiforme (GBM) patients who underwent postneurosurgical radiotherapy and concurrent plus adjuvant temozolomide. METHODS: The retrospective data of GBM p...

Descripción completa

Detalles Bibliográficos
Autores principales: Topkan, Erkan, Besen, Ali Ayberk, Ozdemir, Yurday, Kucuk, Ahmet, Mertsoylu, Huseyin, Pehlivan, Berrin, Selek, Ugur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262659/
https://www.ncbi.nlm.nih.gov/pubmed/32565725
http://dx.doi.org/10.1155/2020/4392189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262659/
https://www.ncbi.nlm.nih.gov/pubmed/32565725
http://dx.doi.org/10.1155/2020/4392189

Ejemplares similares